Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MetALD”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Not applicableNot Yet RecruitingNCT06907563
What this trial is testing

Long-term Follow-up to Determine Outcome in Liver Disease (LOVE Study)

Who this might be right for
Steatotic Liver DiseaseMASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Steatotic Liver Disease of Mixed Origin (MetALD)+1 more
Universität des Saarlandes 30,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT07024212
What this trial is testing

Phase II Study Evaluating the Efficacy and Safety of DR10624 Injection in MASLD and MetALD Subjects

Who this might be right for
MASLD
Zhejiang Doer Biologics Co., Ltd. 110
Large-scale testing (Phase 3)Not Yet RecruitingNCT07726693
What this trial is testing

Apixaban to Prevent Decompensation of Early Liver Cirrhosis Trial

Who this might be right for
Liver Cirrhosis
University College, London 1,142
Not applicableStudy completedNCT06924281
What this trial is testing

Team Science (The Liver Health Study)

Who this might be right for
Steatotic Liver Disease of Mixed Origin (MetALD)
Brown University 14
Not applicableLooking for participantsNCT07450144
What this trial is testing

A Large Language Model-based Chatbot for Alcohol Reduction in Patients With Metabolic Alcohol-Related Liver Disease

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolic Alcohol-Related Liver Disease
The University of Hong Kong 50
Not applicableEnrolling By InvitationNCT07613827
What this trial is testing

Interventional AI-Human Collaboration for Steatotic Liver Disease Screening

Who this might be right for
Steatotic Liver DiseaseLiver Fibrosis Progression in Chronic Liver DiseaseLiver Steatosis+2 more
Shengjing Hospital 7,969
Not applicableUnknownNCT06514300
What this trial is testing

Investigating Myosteatosis in Steatotic Liver Diseases

Who this might be right for
Alcohol-related Liver DiseaseMetabolic Dysfunction Associated Steatotic Liver DiseaseSteatotic Liver Disease of Mixed Origin (MetALD)+5 more
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 100
Not applicableEnrolling By InvitationNCT06986447
What this trial is testing

Assessment of Non-Invasive Testing in Major Liver-Related Outcomes

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseMASLDMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease+2 more
HRI-MAIL-NIT 1,689
Not applicableNot Yet RecruitingNCT07399600
What this trial is testing

Personalized Transcranial Magnetic Stimulation (TMS) for Metabolic Dysfunction and Alcohol-Related Liver Disease

Who this might be right for
Liver Diseases, AlcoholicFatty LiverMetabolic Syndrome
The Affiliated Hospital of Hangzhou Normal University 105
Large-scale testing (Phase 3)Looking for participantsNCT06461208
What this trial is testing

A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis

Who this might be right for
Liver Cirrhosis
King's College London 300
Testing effectiveness (Phase 2)Looking for participantsNCT07046819
What this trial is testing

Tirzepatide in MetALD

Who this might be right for
Metabolic Alcohol-associated Liver DiseaseAlcohol Use Disorder
National Institute on Alcohol Abuse and Alcoholism (NIAAA) 120